These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23032716)

  • 1. Do patients with heart failure benefit from coronary artery bypass grafting?
    McGee EC; McCarthy PM
    Curr Opin Cardiol; 2012 Nov; 27(6):629-33. PubMed ID: 23032716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure).
    Petrie MC; Jhund PS; She L; Adlbrecht C; Doenst T; Panza JA; Hill JA; Lee KL; Rouleau JL; Prior DL; Ali IS; Maddury J; Golba KS; White HD; Carson P; Chrzanowski L; Romanov A; Miller AB; Velazquez EJ;
    Circulation; 2016 Nov; 134(18):1314-1324. PubMed ID: 27573034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of congestive heart failure in coronary artery disease.
    Benetis R
    Rocz Akad Med Bialymst; 2005; 50():45-9. PubMed ID: 16358938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.
    Wrobel K; Stevens SR; Jones RH; Selzman CH; Lamy A; Beaver TM; Djokovic LT; Wang N; Velazquez EJ; Sopko G; Kron IL; DiMaio JM; Michler RE; Lee KL; Yii M; Leng CY; Zembala M; Rouleau JL; Daly RC; Al-Khalidi HR
    Circulation; 2015 Aug; 132(8):720-30. PubMed ID: 26304663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
    Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
    Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery surgery for ischemic heart failure: risks, benefits, and the importance of assessment of myocardial viability.
    Pitt M; Lewis ME; Bonser RS
    Prog Cardiovasc Dis; 2001; 43(5):373-86. PubMed ID: 11251125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery bypass grafting with concomitant cardiac resynchronisation therapy in patients with ischaemic heart failure and left ventricular dyssynchrony.
    Pokushalov E; Romanov A; Prohorova D; Cherniavsky A; Goscinska-Bis K; Bis J; Bochenek A; Karaskov A
    Eur J Cardiothorac Surg; 2010 Dec; 38(6):773-80. PubMed ID: 20447832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons.
    Ogawa M; Doi K; Fukumoto A; Yaku H
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):673-5. PubMed ID: 17670732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An approach to the rational use of revascularization in heart failure patients.
    Rouleau JL; Bonow RO
    Can J Cardiol; 2014 Mar; 30(3):281-7. PubMed ID: 24484914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical therapy for ischemic cardiomyopathy].
    Ikeda Y; Kurazumi H; Sato M; Suzuki R; Shirasawa B; Mikamo A; Hamano K
    Kyobu Geka; 2012 Feb; 65(2):89-97. PubMed ID: 22314161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
    MacDonald MR; She L; Doenst T; Binkley PF; Rouleau JL; Tan RS; Lee KL; Miller AB; Sopko G; Szalewska D; Waclawiw MA; Dabrowski R; Castelvecchio S; Adlbrecht C; Michler RE; Oh JK; Velazquez EJ; Petrie MC
    Eur J Heart Fail; 2015 Jul; 17(7):725-34. PubMed ID: 26011509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
    Velazquez EJ; Lee KL; O'Connor CM; Oh JK; Bonow RO; Pohost GM; Feldman AM; Mark DB; Panza JA; Sopko G; Rouleau JL; Jones RH;
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1540-7. PubMed ID: 18023680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic value of muscular counterpulsation after coronary bypass grafting operation.
    Lapanashvili LV; Buziashvili YI; Matskeplishvili ST; Lobjanidze TG; Yoshina VI; Kamardinov DK; Tugeeva EF; Bockeria LA
    J Card Surg; 2009; 24(2):134-40. PubMed ID: 18793232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of patients undergoing surgical ventricular reconstruction by choice and by randomization.
    Zembala M; Michler RE; Rynkiewicz A; Huynh T; She L; Lubiszewska B; Hill JA; Jandova R; Dagenais F; Peterson ED; Jones RH
    J Am Coll Cardiol; 2010 Aug; 56(6):499-507. PubMed ID: 20670761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcome of Intra-Myocardial Injection of Autologous Bone Marrow Mononuclear Cells Combined with Isolated Coronary Artery Bypass Grafting for Patients with Chronic Ischemic Heart Failure.
    Wang R; Zhang L; Wang Y; Gong Z; Xiao C; Wu Y; Ren C; Cheng N; Gao C
    Heart Surg Forum; 2016 Jun; 19(3):E131-8. PubMed ID: 27355149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery bypass surgery in patients with severe left-ventricular dysfunction.
    Olsen PS; Kassis E; Niebuhr-Jørgensen U
    Thorac Cardiovasc Surg; 1993 Apr; 41(2):118-20. PubMed ID: 8372390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision support in surgical management of ischemic cardiomyopathy.
    Yoon DY; Smedira NG; Nowicki ER; Hoercher KJ; Rajeswaran J; Blackstone EH; Lytle BW
    J Thorac Cardiovasc Surg; 2010 Feb; 139(2):283-93, 293.e1-7. PubMed ID: 20106391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revascularization for heart failure.
    Phillips HR; O'Connor CM; Rogers J
    Am Heart J; 2007 Apr; 153(4 Suppl):65-73. PubMed ID: 17394905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction.
    DeRose JJ; Toumpoulis IK; Balaram SK; Ioannidis JP; Belsley S; Ashton RC; Swistel DG; Anagnostopoulos CE
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):314-21. PubMed ID: 15678041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heartmate II implantation with right coronary bypass grafting in ischemic cardiomyopathy with "fixed" pulmonary hypertension: treatment strategy to protect right ventricular function.
    Sommer SP; Gorski A; Aleksic I; Yildirim C; Schimmer C; Beissert M; Weininger M; Leyh RG
    J Card Surg; 2010; 25(1):116-9. PubMed ID: 19549043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.